|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2005-12-23
|
|
pubmed:abstractText |
Metalloproteinases are proteolytic enzymes, which decompose the extracellular matrix, influence cardiac remodelling, and are inhibited by tissue inhibitor of metalloproteinases (TIMPs). Little is known about the prognostic impact of the TIMP-1/matrix metalloproteinase complex in patients with future cardiovascular death.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0195-668X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
27
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
150-6
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16230310-Biological Markers,
pubmed-meshheading:16230310-Cardiovascular Diseases,
pubmed-meshheading:16230310-Coronary Artery Disease,
pubmed-meshheading:16230310-Female,
pubmed-meshheading:16230310-Follow-Up Studies,
pubmed-meshheading:16230310-Humans,
pubmed-meshheading:16230310-Male,
pubmed-meshheading:16230310-Middle Aged,
pubmed-meshheading:16230310-Prognosis,
pubmed-meshheading:16230310-Risk Factors,
pubmed-meshheading:16230310-Tissue Inhibitor of Metalloproteinase-1
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Prognostic value of tissue inhibitor of metalloproteinase-1 for cardiovascular death among patients with cardiovascular disease: results from the AtheroGene study.
|
|
pubmed:affiliation |
Department of Medicine II, Johannes Gutenberg-University, Langenbeckstrasse 1, 55101 Mainz, Germany. edithlubos@gmx.de
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
